LBT Innovations wins crucial European approvals

Medical technology developer LBT Innovations (ASX: LBT) has won European CE mark certification for its APAS Independence laboratory instrument, allowing sale in all European countries. The company has identified 130 priority customers among laboratories in Europe, and will follow its successful strategy of placing its instruments with the laboratories for performance evaluation. APAS is an…

USCOM reports higher sales after reorganisation

Cardiovascular disease monitoring technology company USCOM has posted a smaller loss for the 2019 financial year following the reorganisation of manufacturing. The company, founded in 2000 on cardiovascular research by at the University of Queensland, reported revenues of $3.64 million and total costs of $4.3 million. UNSCOM makes a range of non-invasive cardiovascular and pulmonary…

Services drive Cochlear profits in competitive implant market

Services are increasingly driving profit growth for bionic ear manufacturer Cochlear (ASX: COH) in an increasingly competitive medical device market. The Sydney company sold 34,083 hearing implants in the year, down three per cent, as competitor new product launches in the United States and Germany hit sales. However sales are growing again with the launch…